Obesity is reaching epidemic proportions in the U.S. and poses a serious public health burden due to a wide range of cdmorbidities. Two of the most common complications of obesity are sleep apnea (SA) and type 2 diabetes, and recent evidence suggests that the intermittent hypoxia (IH)and sleep fragmentation (SF) that characterize sleep apnea may independently cause glucose intolerance and insulin resistance and accelerate the process by which obesity leads to diabetes. Potentially both the IH and SF may affect metabolic function, and the major purpose of the current proposal is to delineate the pathways and mechanisms through which IH and SF lead to glucose intolerance and insulin resistance. We propose that impaired signaling of leptin and melanocortin pathways, which normally regulate food intake, metabolism, and insulin sensitivity of peripheral tissues can cause insulin resistance in the presence of IH. Furthermore, we propose that SF can act through different pathways to produce insulin resistance by stimulating the sympathoadrenal axis. Our approach is to examine the effects of validated models of IH and SF in normal and obesity/diabetic prone inbred mice, and to utilize specific transgenic and knockout mice to explore the functional significance of leptin, melanocortin, and adrenergic pathways. We will employ state-of-the-art clinical parameters for measurement of insulin sensitivity (hyperinsulinemic euglycemic clamp), glucose tolerance (intravenous glucose tolerance test), and hepatic glucose output. Specifically, we propose: (1) To determine the magnitude of insulin resistance that occurs in wildtype and leptin-deficient mice exposed to IH and SF, and whether central and peripheral administration of exogenous leptin protects against insulin resistance during IH and SF. (2) To investigate whether endogenous or exogenous blockade of the melanocortin pathway leads to insulin resistance during IH and SF. (3) To examine the role of the role of a-adrenergic receptors and corticosterone increasing insulin resistance, and /?3-adrenergic receptors decreasing insulin resistance in response to IH and SF. The proposed experiments will elucidate causative pathways through which IH and SF lead to insulin resistance in peripheral tissues and identify potential intervention sites for reducing the risk of sleep apnea accelerating the progression of insulin resistance in obese patients.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL063767-08
Application #
7540406
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Twery, Michael
Project Start
1999-12-01
Project End
2010-11-30
Budget Start
2008-12-01
Budget End
2009-11-30
Support Year
8
Fiscal Year
2009
Total Cost
$287,847
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Lakshmipathi, Jayalakshmi; Alvarez-Perez, Juan Carlos; Rosselot, Carolina et al. (2016) PKC? Is Essential for Pancreatic ?-Cell Replication During Insulin Resistance by Regulating mTOR and Cyclin-D2. Diabetes 65:1283-96
Lee, Euhan J; Alonso, Laura C; Stefanovski, Darko et al. (2013) Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia. Eur J Appl Physiol 113:467-78
Alonso, Laura C; Watanabe, Yoshio; Stefanovski, Darko et al. (2012) Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice. Obesity (Silver Spring) 20:1403-12
Pascoe, Jordan; Hollern, Douglas; Stamateris, Rachel et al. (2012) Free fatty acids block glucose-induced ?-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18. Diabetes 61:632-41
Dempsey, Jerome A; Veasey, Sigrid C; Morgan, Barbara J et al. (2010) Pathophysiology of sleep apnea. Physiol Rev 90:47-112
Lee, Euhan J; Woodske, Matthew E; Zou, Baobo et al. (2009) Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol (1985) 107:290-4
Sanders, Mark H; Montserrat, Josep M; Farre, Ramon et al. (2008) Positive pressure therapy: a perspective on evidence-based outcomes and methods of application. Proc Am Thorac Soc 5:161-72
Yokoe, Takuya; Alonso, Laura C; Romano, Lia C et al. (2008) Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 586:899-911
Iiyori, Nao; Alonso, Laura C; Li, Jianguo et al. (2007) Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity. Am J Respir Crit Care Med 175:851-7
Polotsky, Vsevolod Y; Rubin, Arnon E; Balbir, Alex et al. (2006) Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med 7:7-16

Showing the most recent 10 out of 15 publications